Sign In
Buy GENE
$0.765
+0 (+0%)
At Close: Jan 15, 2025
Fractyl Health to Present at Chardan's 8th Annual Genetic Medicines Conference
07:00am, Tuesday, 24'th Sep 2024
BURLINGTON, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root cau
Dyne Therapeutics to Present at Chardan's 8th Annual Genetic Medicines Conference
08:56am, Monday, 23'rd Sep 2024
WALTHAM, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for peo
Join Genetic Technology's Exclusive Live Investor Webinar and Q&A Session on October 2
08:30am, Monday, 23'rd Sep 2024
MELBOURNE, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driv
Passage Bio to Present at Chardan's 8th Annual Genetic Medicines Conference
07:00am, Monday, 23'rd Sep 2024
PHILADELPHIA, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases
Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference
07:15pm, Thursday, 19'th Sep 2024
EMERYVILLE, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its propri
Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics
08:15am, Wednesday, 11'th Sep 2024
MELBOURNE, Australia, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness a
Fulcrum Therapeutics Upgraded: BofA Debates Pivotal Study Success For Losmapimod In Rare Genetic Muscle Disease
02:28pm, Monday, 09'th Sep 2024
BofA Securities has upgraded Fulcrum Therapeutics FULC ahead of the company's phase 3 losmapimod readout, expected by the end of October for Facioscapulohumeral muscular dystrophy (FSHD).
Eli Lilly signs research deal with AI-focused Genetic Leap
09:33am, Thursday, 05'th Sep 2024
Eli Lilly has entered into a research deal with artificial intelligence-focused firm Genetic Leap for up to $409 million to develop genetic medicines, the latter said on Thursday.
CENTOGENE Publication in Brain Journal Reveals 15% of Parkinson's Disease Cases Are Linked to Genetic Factors
04:15pm, Thursday, 01'st Aug 2024
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerat
Genetic Technologies Strategic Restructure Driving USA Sales Growth
08:00am, Friday, 26'th Jul 2024
CHARLOTTE, N.C., July 26, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and ser
Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary
08:00am, Tuesday, 16'th Jul 2024
MELBOURNE, Australia, July 16, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness, an
WiMi Announced a Genetic Algorithm-based Consensus Algorithm for Blockchain
09:30am, Monday, 15'th Jul 2024
BEIJING , July 15, 2024 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced a blo
Ludwig Enterprises Files Provisional Patent on mRNA Genetic Screening Signals in Breast, Colon and Bladder Cancer
08:00am, Tuesday, 09'th Jul 2024
SPARKS, NV / ACCESSWIRE / July 9, 2024 / Ludwig Enterprises, Inc, (OTC PINK:LUDG), a USA based biotechnology company is pleased to announce that the company has filed a provisional patent titled "mRNA
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
08:00am, Tuesday, 25'th Jun 2024
CHARLOTTE, N.C., June 25, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and seri
Join Genetic Technologies' Exclusive Live Investor Webinar and Q&A Session on June 27
08:00am, Friday, 21'st Jun 2024
CHARLOTTE, N.C. and MELBOURNE, Australia, June 21, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, ASX:GTG, “Company”, “GTG”, or “Genetic Technologies”), a global leade
